Personalized glucose-lowering effect of chiglitazar in type 2 diabetes
Summary: Chiglitazar (carfloglitazar) is a peroxisome proliferator-activated receptor pan-agonist presenting non-inferior glucose-lowering efficacy with sitagliptin in patients with type 2 diabetes. To delineate the subgroup of patients with greater benefit from chiglitazar, we conducted a machine l...
| 發表在: | iScience |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Elsevier
2023-11-01
|
| 主題: | |
| 在線閱讀: | http://www.sciencedirect.com/science/article/pii/S2589004223022721 |